Methylome Study in Patients Affected With Sporadic Limb Malformations
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Differentially Methylated Regions
研究概览
简要总结
Some limb malformations are known to be sporadic (non hereditary). For these malformations, no molecular cause was identified, even after whole genome sequencing. Methylation of CpG islands is an epigenetic process which is usually not transmitted to the descents. We hypothesize that sporadic limb malformations may be due to a methylation anomaly. This study will include patients with Amelia or Femur Fibula Ulna Syndrome. With patients consent, we will study the methylome on DNA samples already available in our laboratory. Each patient sample will be paired to a control of same tissue, age and sex. By bioinformatics comparison, we will identify differentially methylated candidate regions.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Specific consent for this study
- •DNA available in the laboratory
- •For amelia : agenesia of 2 or 4 limbs
- •For Femur-Fibula-Ulna Syndrome : hypoplasia or agenesia of the femur uni or bilateral with hypoplasia or agenesia or bowing of the fibula and/or of the ulna
排除标准
- •No consent
- •No available DNA or poor quality of the DNA sample
- •Patient under tutorship
- •Pregnancy or nursing mother
- •Patient non covered by the French social security
结局指标
主要结局
Differentially Methylated Regions
时间窗: through study completion an average of 3 years
次要结局
未报告次要终点
